SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial...
Health and medicine
Human Tissue Engineering Company Prellis Biologics Raises $8.7 Million Series A Round; Announces First Animal Transplant of Its 3D-Printed Tissue
Lead investor Khosla Ventures backs Prellis’ mission to create viable human tissue and organs for transplant July 30, 2019 11:38 AM Eastern Daylight Time – SAN FRANCISCO–(BUSINESS WIRE)–Prellis...
